These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CD1a-positive familial cutaneous mastocytosis without germ-line or somatic mutations in c-kit. Arase N; Wataya-Kaneda M; Oiso N; Arase H; Katayama I Br J Dermatol; 2013 Jul; 169(1):201-4. PubMed ID: 23834123 [No Abstract] [Full Text] [Related]
3. A case of cutaneous mastocytosis in a child with prominent Langerhans cell infiltration. Mitsuya J; Hara H; Fukuda N; Terui T Pediatr Dermatol; 2011; 28(4):412-5. PubMed ID: 20738800 [TBL] [Abstract][Full Text] [Related]
11. SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis. Sugimoto A; Kataoka TR; Ueshima C; Takei Y; Kitamura K; Hirata M; Nomura T; Haga H Exp Dermatol; 2018 Jun; 27(6):641-646. PubMed ID: 29498772 [TBL] [Abstract][Full Text] [Related]
13. Two cases of telangiectasia macularis eruptiva perstans demonstrated by immunohistochemistry for c-kit (CD 117). Lee HW; Jeong YI; Choi JC; Lee MW; Choi JH; Moon KC; Koh JK J Dermatol; 2005 Oct; 32(10):817-20. PubMed ID: 16361734 [TBL] [Abstract][Full Text] [Related]
14. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. Bodemer C; Hermine O; Palmérini F; Yang Y; Grandpeix-Guyodo C; Leventhal PS; Hadj-Rabia S; Nasca L; Georgin-Lavialle S; Cohen-Akenine A; Launay JM; Barete S; Feger F; Arock M; Catteau B; Sans B; Stalder JF; Skowron F; Thomas L; Lorette G; Plantin P; Bordigoni P; Lortholary O; de Prost Y; Moussy A; Sobol H; Dubreuil P J Invest Dermatol; 2010 Mar; 130(3):804-15. PubMed ID: 19865100 [TBL] [Abstract][Full Text] [Related]
15. Mastocytosis: state of the art. Horny HP; Sotlar K; Valent P Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883 [TBL] [Abstract][Full Text] [Related]
16. Mastocytosis in children: clinicopathological study based on 35 cases. Kiszewski AE; Alvarez-Mendoza A; Ríos-Barrera VA; Hernández-Pando R; Ruiz-Maldonado R Histol Histopathol; 2007 May; 22(5):535-9. PubMed ID: 17330808 [TBL] [Abstract][Full Text] [Related]
17. Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis? Georgin-Lavialle S; Le Saché-de Peufeilhoux L; Martin L; Soucie E; Bruneau J; Barete S; Dubreuil P; Bodemer C; Hermine O; Lhermitte L J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):967-71. PubMed ID: 23763569 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374 [TBL] [Abstract][Full Text] [Related]
19. Exploring the mast cell enigma: a personal reflection of what remains to be done. Henz BM Exp Dermatol; 2008 Feb; 17(2):91-9. PubMed ID: 18205712 [TBL] [Abstract][Full Text] [Related]
20. [Systemic mastocytosis]. Niedoszytko M; Lange M; Chelminska M; Jaśkiewicz K; Piskosz A; Wasag B; Lewandowski K; Mital A; Renke J; Gruchała-Niedoszytko M; Woźniak M; Babińska A; Jassem E Pneumonol Alergol Pol; 2005; 73(3):239-44. PubMed ID: 16989160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]